Articles for GlaxoSmithKline (LSE: GSK)

3 dividend champions in the making

These three companies could deliver dream dividends, says G A Chester. More »

What GlaxoSmithKline plc’s choice of CEO means for shareholders

Will GlaxoSmithKline plc's (LON: GSK) new CEO be a blessing or a curse for shareholders? More »

Is Sinclair Pharma plc a better bet than GlaxoSmithKline plc?

Does Sinclair Pharma plc (LON: SPH) have the growth potential to bring you more riches than GlaxoSmithKline plc (LON: GSK)? More »

Should you buy GlaxoSmithKline plc after its change in CEO?

Is GlaxoSmithKline plc (LON: GSK) more or less appealing after a change in senior management? More »

These two large caps look seriously undervalued

These two large caps could be the most undervalued in the FTSE 100. More »

Should you buy this healthcare company after its 39% fall?

This healthcare stock has endured a tough year, but is now the time to buy? More »

Why Vectura group plc and GlaxoSmithKline plc could be the perfect combination

GlaxoSmithKline plc (LON: GSK) and Vectura Group plc (LON: VEC) have many complementary qualities. More »

Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after today’s news?

Royston Wild weighs up the investment potential of drugs deities Dechra Pharmaceuticals plc (LON: DPH) and GlaxoSmithKline plc (LON: GSK). More »

Is this the best healthcare stock money can buy after today’s update?

Should you buy this healthcare stock as it announces moves to boost its bottom line, or are two larger sector peers better bets? More »

How safe is GlaxoSmithKline plc’s dividend?

Are dividends built to endure at GlaxoSmithKline plc (LON: GSK), or is trouble ahead? More »

Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update?

Edward Sheldon looks at Hikma Pharmaceuticals plc's (LON: HIK) interim results statement and examines whether the long-term growth story is still intact. More »

Which of these Neil Woodford dividend stocks should you buy today?

Roland Head takes a look at two of star fund manager Neil Woodford's top income holdings. More »

Are these 3 top stocks still mighty income machines?

The search for a higher yield on your savings should start with these three stocks, says Harvey Jones. More »

3 blue chip bargains you can’t afford to miss!

Royston Wild looks at three FTSE 100 (INDEXFTSE: UKX) stars dealing far too cheaply at current prices. More »

Now is the perfect time to buy these 3 healthcare stocks!

These three companies have stunning long-term return potential. More »

Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?

After recent gains is it time to sell GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)? More »

Is this stock the best buy in its sector following today’s update?

Should you buy this stock over two industry peers? More »

Are GlaxoSmithKline plc and GW Pharmaceuticals plc simply too expensive?

How much should you pay for GlaxoSmithKline plc (LON:GSK) and GW Pharmaceuticals plc (LON:GWP)? More »

What can Google do that GlaxoSmithKline plc cannot?

VIDEO: One Fool takes a look under the hood at GlaxoSmithKline plc (LON:GSK). More »

Is it too late to buy GlaxoSmithKline plc, Glencore plc and Royal Bank of Scotland Group plc?

Royston Wild considers whether FTSE 100 (INDEXFTSE: UKX) surgers GlaxoSmithKline plc (LON: GSK), Glencore plc (LON: GLEN) and Royal Bank of Scotland Group plc... More »

Your browser (Internet Explorer 8 or older) is out of date. It has known security flaws and may not display all features of this and other websites. We recommend updating to Google Chrome.